The annual progress report gives a comprehensive overview of the activities and performance of Gavi, the Vaccine Alliance, illustrating the work and achievements of this public-private partnership
The annual progress report gives a comprehensive overview of the activities and performance of Gavi, the Vaccine Alliance, illustrating the work and achievements of this public-private partnership
Gavi also publishes Annual Financial Reports which present annual audited consolidated financial statements.
Highlighting key data, partnerships and milestones, the 2020 Annual Progress Report offers insights into our progress last year, while looking at what’s ahead – including the Vaccine Alliance’s role in the global COVID-19 response.
Explore the report
Highlighting key data, partnerships and milestones, the 2020 Annual Progress Report offers insights into our progress last year, while looking at what’s ahead – including the Vaccine Alliance’s role in the global COVID-19 response.
Explore the reportWelcome to Gavi’s 2020 Annual Progress Report, the fifth in a series of five covering this strategic period.
Welcome to Gavi’s 2019 Annual Progress Report, the fourth in a series of five covering this strategic period.
In this edition of our Annual Progress Report, we look back at the third year of the 2016-2020 strategic period and provide a global context for the work of the Vaccine Alliance.
The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership.
The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership.
Marking the end of GAVI's first decade, the 2010 Progress Report shows how unprecedented demand, accelerated access to vaccines and strong country ownership have helped save over five million future deaths.
GAVI's 2009 Progress Report paints a picture of developing country commitment and ownership of GAVI programmes. By the end of the year, over 250 million additional children had been vaccinated through GAVI support.
By the end of 2008, 3.4 million future deaths have been averted through GAVI support for vaccines. In 2008, GAVI undergoes governance and administrative changes, becoming a Swiss international organisation.
2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.
Gavi Progress Report 2007 Summary
2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.
This report for 2006 is the first of the new 10-year phase of operations which will take us to 2015 and beyond.
In the first five years of GAVI, 15 million more children were reached with basic vaccines, 99 million were reached with new vaccines and 1.2 billion auto-disable syringes were delivered.
After five years in operation, 71 countries out of 75 GAVI-eligible countries have received GAVI support, with one third of resources directed toward strengthening health systems in poorest countries.
